ARQT
Arcutis Biotherapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.94B
P/E Ratio
—
EPS
$-0.13
Beta
1.59
52W High
$31.77
52W Low
$12.42
50-Day MA
$23.82
200-Day MA
$22.88
Dividend Yield
—
Profit Margin
-4.29%
Forward P/E
129.87
PEG Ratio
—
About Arcutis Biotherapeutics Inc
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company is headquartered in Westlake Village, California.
Fundamentals
| Revenue (TTM) | $376.07M |
| Gross Profit (TTM) | $339.38M |
| EBITDA | $-7.56M |
| Operating Margin | 14.20% |
| Return on Equity | -9.30% |
| Return on Assets | -1.96% |
| Revenue/Share (TTM) | $2.96 |
| Book Value | $1.54 |
| Price-to-Book | 15.41 |
| Price-to-Sales (TTM) | 7.81 |
| EV/Revenue | 7.48 |
| EV/EBITDA | 1580.03 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 81.50% |
| Shares Outstanding | $125.07M |
| Float | $92.18M |
| % Insiders | 1.78% |
| % Institutions | 107.81% |
Historical Volatility
HV 10-Day
44.18%
HV 20-Day
41.85%
HV 30-Day
50.31%
HV 60-Day
54.40%
HV Rank
41.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($34.75 target)
2
Strong Buy5
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/5/2026